|3Oct 28, 12:12 PM ET

NOVARTIS AG 3

3 · Tourmaline Bio, Inc. · Filed Oct 28, 2025

Insider Transaction Report

Form 3
Period: 2025-10-28
NOVARTIS AG
10% Owner
Holdings
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    24,030,382
Footnotes (1)
  • [F1]These shares are owned directly by Torino Merger Sub Inc., an indirect wholly-owned subsidiary of Novartis AG.

Documents

1 file
  • 3
    tm2529487-1_3seq1.xmlPrimary

    OWNERSHIP DOCUMENT